Insulin Sensitivity and Plasma Glucose Appearance Profile by Oral Minimal Model in Normotensive and Normoglycemic Humans

  • Roberto Burattini
  • Fabrizio Casagrande
  • Francesco Di Nardo
  • Massimo Boemi
  • Pierpaolo Morosini
Part of the Lecture Notes in Computer Science book series (LNCS, volume 4345)


To evaluate the whole body insulin sensitivity, S IW , and the rate of appearance, R a (t), of ingested glucose into plasma, the oral minimal model of glucose kinetics (OMM) was applied to insulinemia and glycemia data from six volunteer, normotensive and normoglycemic subjects, who underwent a 300 min oral glucose tolerance test (OGTT). Results from a full 22-sampling schedule (OGTT300/22), were compared with two reduced schedules consisting of 12 samples (OGTT300/12) and 11 samples (OGTT300/11), respectively. The three protocols yielded virtually the same values of insulin sensitivity (denoted as S 22 IW , S 12 IW and S 11 IW , respectively) with intraclass correlation coefficients being not lower than 0.74. The R a (t) profiles reproduced by the OMM after application to the OGTT300/22 and the OGTT300/12 data were practically indistinguishable, whereas the profile obtained from the OGTT300/11 was characterized by a 33% overshoot at the 30th minute, followed by a 22% undershoot at the 60th minute. Our results suggest that the reduced OGTT300/12is suitable to facilitate the assessment of insulin sensitivity and plasma glucose appearance profile in pathophysiological studies by the OMM.


Glucose kinetics insulin action metabolic syndrome OGTT 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Breda, E., Cavaghan, M.K., Toffolo, G., Polonsky, K.S., Cobelli, C.: Oral glucose tolerance test minimal model indexes of ß-cell function and insulin sensitivity. Diabetes 50, 150–158 (2001)CrossRefGoogle Scholar
  2. 2.
    Dalla Man, C., Caumo, A., Cobelli, C.: The oral glucose minimal model: estimation of insulin sensitivity from a meal test. IEEE Trans. Biomed. Eng. 49, 419–429 (2002)CrossRefGoogle Scholar
  3. 3.
    Dalla Man, C., Yarasheski, K.E., Caumo, A., Robertson, H., Toffolo, G., Polonsky, K.S., Cobelli, C.: Insulin sensitivity by oral glucose minimal models: validation against clamp. Am. J Physiol. Endocrinol. Metab. 289, E954–E959 (2005)CrossRefGoogle Scholar
  4. 4.
    Dalla Man, C., Campioni, M., Polonsky, K.S., Basu, R., Rizza, R.A., Toffolo, G., Cobelli, C.: Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals. Diabetes 54, 3265–3273 (2005)CrossRefGoogle Scholar
  5. 5.
    Di Nardo, F., Casagrande, F., Boemi, M., Fumelli, P., Morosini, P., Burattini, R.: Insulin resistance in hypertension quantified by oral glucose tolerance test: comparison of methods. Metabolism 55, 143–150 (2006)CrossRefGoogle Scholar
  6. 6.
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): JAMA 285, 2486–2497 (2001)Google Scholar
  7. 7.
    SAAM Institute: SAAM II User Guide. Seattle, WA (1997)Google Scholar
  8. 8.
    Barrett, P.H., Bell, B.M., Cobelli, C., Golde, H., Schumitzky, A., Vicini, P., Foster, D.M.: SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies. Metabolism 47, 484–492 (1998)CrossRefGoogle Scholar
  9. 9.
    Carson, E.R., Cobelli, C., Finkelstein, L.: The Mathematical Modeling of Metabolic and Endocrine Systems. Wiley, New York (1983)Google Scholar
  10. 10.
    Fleiss, J.L.: Statistical Methods for Rates and Proportion, pp. 212–236. Wiley, New York (1980)Google Scholar
  11. 11.
    Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M.A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., Bevilacqua, S.: Insulin resistance in essential hypertension. N. Engl. J. Med. 317, 350–357 (1987)CrossRefGoogle Scholar
  12. 12.
    Corry, D.B., Tuck, M.L.: Glucose and insulin metabolism in hypertension. Am. J. Nephrol. 16, 223–236 (1996)CrossRefGoogle Scholar
  13. 13.
    Burattini, R., Di Nardo, F., Boemi, M., Fumelli, P.: Deterioration of insulin sensitivity and glucose effectiveness with age and hypertension. Am. J. Hypertens 19, 98–102 (2006)CrossRefGoogle Scholar
  14. 14.
    Kieffer, T.J., Habener, J.F.: The glucagon-like peptides. Endocr. Rev. 20, 876–913 (1999)CrossRefGoogle Scholar
  15. 15.
    Wachters-Hagedoorn, R.E., Priebe, M.G., Heimweg, J.A., Heiner, A.M., Englyst, K.N., Holst, J.J., Stellaard, F., Vonk, R.J.: The rate of intestinal glucose absorption is correlated with plasma glucose-dependent insulinotropic polypeptide concentrations in healthy men. J. Nutr. 136, 1511–1516 (2006)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2006

Authors and Affiliations

  • Roberto Burattini
    • 1
  • Fabrizio Casagrande
    • 1
  • Francesco Di Nardo
    • 1
  • Massimo Boemi
    • 2
  • Pierpaolo Morosini
    • 3
  1. 1.Department of Electromagnetics and BioengineeringPolytechnic University of MarcheAnconaItaly
  2. 2.Metabolic Disease and Diabetes Unit, Italian National Institute of Research and Care on Aging (INRCA-IRCCS)AnconaItaly
  3. 3.Unit of Internal Medicine, “C. G. Mazzoni” General HospitalAscoli PicenoItaly

Personalised recommendations